Syntho Pharmaceuticals, Inc. is recalling approximately 10,000 bottles of EEMT and EEMT HS (esterified estrogens and methyltestosterone) tablets. These prescription hormone replacement medications were found to be sub-potent, meaning they contain less of the active ingredient than required, and were manufactured under conditions that violated current Good Manufacturing Practice (cGMP) standards. Consumers who use these medications may not receive the intended therapeutic benefit, which could lead to a recurrence of symptoms. You should consult with your healthcare provider or pharmacist regarding the continued use of this product and to arrange for a suitable replacement.
The sub-potency of these hormone tablets means patients may receive an inadequate dose of medication, potentially leading to the return of symptoms or ineffective treatment of the underlying condition. Manufacturing violations further compromise the quality and reliability of the drug product.
Drug recall baseline remedy
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.